• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解冻后CD34+细胞回收率在极高的移植物血小板浓度下可能会降低。

Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations.

作者信息

Duarte Gustavo C, Ladvanszky Leandro, Atkinson Gavin, Burns Michelle, Madola Dona, Sadani Deepak, Yan-Fischer Marcus, Patel Hemant, Tremblay Jacynthe, Butler Andrew, Rathod Niranjan, Wei Wen-Hua

机构信息

New Zealand Blood Service, 15 Lester Lane, Christchurch, New Zealand.

New Zealand Blood Service, 71 Great South Road, Auckland, New Zealand.

出版信息

Bone Marrow Transplant. 2024 Dec;59(12):1704-1709. doi: 10.1038/s41409-024-02409-w. Epub 2024 Sep 16.

DOI:10.1038/s41409-024-02409-w
PMID:39284873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11611725/
Abstract

Impaired post-thaw CD34 cell (postCD34) viability in autologous haematopoietic stem cell transplant (ASCT) could indicate delayed engraftment where multiple factors might complicate the relationship. Despite of a couple of unconfirmed reports of a negative correlation of platelet concentration with postCD34 viability, how platelets might be involved in the relationship is largely unknown. Therefore, this question was addressed in this retrospective study of 82 ASCT patients with a total of 150 collections of peripheral blood stem cells in New Zealand. A significant negative correction between platelet concentration and postCD34 recovery (r = -0.18, p = 0.028) was observed overall, but upon further analysis only confirmed in the subset with graft platelets 1500-2000 ×10/L. Importantly, the postCD34 recovery was clearly reduced in the subgroups with either the lowest or the highest platelet concentration. The lowest subgroup was enriched with collections from patients with Hodgkin or non-Hodgkin lymphoma, whereas the highest subgroup from patients with multiple myeloma, both with clearly male preponderance. We hypothesized that graft platelet concentrations probably indicated CD34 cell state (e.g. cell cycle and cell adhesion highly related to platelet functions) that sustained when platelet concentrations were within a niche range but went out of kilter otherwise.

摘要

在自体造血干细胞移植(ASCT)中,解冻后CD34细胞(postCD34)活力受损可能表明植入延迟,而多种因素可能使这种关系变得复杂。尽管有一些未经证实的报告称血小板浓度与postCD34活力呈负相关,但血小板在这种关系中可能如何起作用在很大程度上尚不清楚。因此,在这项对新西兰82例ASCT患者进行的回顾性研究中,共采集了150份外周血干细胞样本,探讨了这个问题。总体上观察到血小板浓度与postCD34恢复之间存在显著的负相关(r = -0.18,p = 0.028),但进一步分析仅在移植血小板为1500 - 2000×10⁹/L的亚组中得到证实。重要的是,在血小板浓度最低或最高的亚组中,postCD34恢复明显降低。血小板浓度最低的亚组中,霍奇金淋巴瘤或非霍奇金淋巴瘤患者的采集样本较多,而血小板浓度最高的亚组中,多发性骨髓瘤患者的采集样本较多,这两个亚组男性均占明显优势。我们推测,移植血小板浓度可能表明了CD34细胞状态(例如与血小板功能高度相关的细胞周期和细胞黏附),当血小板浓度在特定范围内时这种状态得以维持,否则就会失衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac18/11611725/03629af16fad/41409_2024_2409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac18/11611725/03629af16fad/41409_2024_2409_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac18/11611725/03629af16fad/41409_2024_2409_Fig1_HTML.jpg

相似文献

1
Post-thaw CD34+ cell recovery likely degraded under extreme graft platelet concentrations.解冻后CD34+细胞回收率在极高的移植物血小板浓度下可能会降低。
Bone Marrow Transplant. 2024 Dec;59(12):1704-1709. doi: 10.1038/s41409-024-02409-w. Epub 2024 Sep 16.
2
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.移植的 CD34(+) 细胞剂量与非霍奇金淋巴瘤或多发性骨髓瘤患者自体外周血造血干细胞移植后血小板计数的长期恢复有关。
Biol Blood Marrow Transplant. 2011 Aug;17(8):1146-53. doi: 10.1016/j.bbmt.2010.11.021. Epub 2010 Nov 30.
3
CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.移植外周血 CD34+ 细胞上的 CXCR4 表达:与多发性骨髓瘤患者自体移植后植入的关系。
Ann Hematol. 2011 May;90(5):547-55. doi: 10.1007/s00277-010-1097-8. Epub 2010 Oct 19.
4
Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantation.自体造血细胞移植中,输注前、解冻后CD34+外周血干细胞计数作为造血植入的预测指标。
Transfus Apher Sci. 2014 Jun;50(3):443-50. doi: 10.1016/j.transci.2014.02.021. Epub 2014 Mar 12.
5
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.预测淋巴瘤或骨髓瘤自体干细胞移植后血小板延迟恢复的因素。
Ann Hematol. 2020 Dec;99(12):2893-2901. doi: 10.1007/s00277-020-04112-4. Epub 2020 Jun 22.
6
CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcome.淋巴瘤中造血血细胞采集的CD34+选择及自体移植:4℃过夜储存细胞不影响结果。
Bone Marrow Transplant. 2000 Mar;25(5):559-66. doi: 10.1038/sj.bmt.1702175.
7
High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.高CD34+细胞剂量可促进急性髓系白血病自体干细胞移植后血小板更快恢复。
Biol Blood Marrow Transplant. 2003 Oct;9(10):643-8. doi: 10.1016/s1083-8791(03)00232-5.
8
Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.在多发性骨髓瘤自体干细胞移植后,移植物中未达到CD34+CD110+祖细胞的阈值剂量预示着血小板植入延迟。
Biol Blood Marrow Transplant. 2009 Nov;15(11):1386-93. doi: 10.1016/j.bbmt.2009.06.018. Epub 2009 Aug 19.
9
Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.解冻后存活的CD34(+)细胞计数是自体外周血干细胞移植中造血干细胞植入的一个有价值的预测指标。
Vox Sang. 2008 Feb;94(2):146-52. doi: 10.1111/j.1423-0410.2007.01009.x. Epub 2007 Nov 19.
10
Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.确定冷冻保存的造血祖细胞解冻后的CD34+细胞剂量显示出高回收率并证实了它们的完整性。
Vox Sang. 2008 May;94(4):351-7. doi: 10.1111/j.1423-0410.2007.001028.x. Epub 2008 Jan 2.

本文引用的文献

1
Insight into the mechanism of CD34 cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.深入了解接受抗CD38治疗的多发性骨髓瘤患者中CD34细胞动员受损的机制。
Br J Haematol. 2024 Apr;204(4):1439-1449. doi: 10.1111/bjh.19141. Epub 2023 Oct 9.
2
Stem-Cell Aging and Pathways to Precancer Evolution.干细胞衰老与癌前病变进展途径
N Engl J Med. 2023 Oct 5;389(14):1310-1319. doi: 10.1056/NEJMra2304431.
3
A critical assessment of dose effects of post-thaw CD34 on autologous stem cell transplantation treatment of haematological malignancies.
解冻后CD34对血液系统恶性肿瘤自体干细胞移植治疗剂量效应的批判性评估。
EJHaem. 2023 Mar 2;4(2):419-427. doi: 10.1002/jha2.665. eCollection 2023 May.
4
Factors influencing post-cryopreserved CD34+ cells viability in the harvested products of autologous haematopoietic stem cells.影响自体造血干细胞采集物中冻存后 CD34+ 细胞活力的因素。
Transfus Clin Biol. 2022 Aug;29(3):224-230. doi: 10.1016/j.tracli.2022.04.001. Epub 2022 Apr 25.
5
Cryopreserved hematopoietic stem/progenitor cells stability program-development, current status and recommendations: A brief report from the AABB-ISCT joint working group cellular therapy product stability project team.冷冻保存造血干细胞/祖细胞稳定性计划的制定、现状和建议:AABB-ISCT 联合工作组细胞治疗产品稳定性项目小组的简要报告。
Transfusion. 2022 Mar;62(3):651-662. doi: 10.1111/trf.16820. Epub 2022 Mar 20.
6
Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.实验室操作对自体外周血造血干细胞移植后细胞活力和造血植入的影响。
Transfusion. 2021 Apr;61(4):1202-1214. doi: 10.1111/trf.16289. Epub 2021 Feb 10.
7
Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources.CD34 亚群的多色免疫表型分析揭示了不同干细胞来源之间意想不到的差异。
Bone Marrow Transplant. 2016 Aug;51(8):1093-100. doi: 10.1038/bmt.2016.88. Epub 2016 Apr 4.
8
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.优化自体干细胞动员策略以改善患者结局:共识指南和建议。
Biol Blood Marrow Transplant. 2014 Mar;20(3):295-308. doi: 10.1016/j.bbmt.2013.10.013. Epub 2013 Oct 17.
9
Hematopoietic stem-cell transplantation.造血干细胞移植
N Engl J Med. 2006 Apr 27;354(17):1813-26. doi: 10.1056/NEJMra052638.
10
Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment.解冻后存活的CD34+细胞和CFU-GM与造血植入时间的关联。
Bone Marrow Transplant. 2005 May;35(9):881-7. doi: 10.1038/sj.bmt.1704926.